Background/Objectives: There are very few publications on unplanned excisions of great saphenous vein leiomyosarcomas (GSV-LMS), and their impact on the prognosis of the disease is not well known. The objective of this study is to present a series of nine new leiomyosarcomas of the great saphena vein (LMS-GSV) cases, with the aim of increasing diagnostic awareness and proposing guidelines for therapeutic management. Methods: This is a prospective single-centre study of a series of nine GSV-LMS in thigh (stage IIIA AJCC), knee and proximal leg (IB, 1 II and 3 IIIA), and ankle (2 IIIB and 1 II). Eight patients were female, and the mean age was 72 years. All patients were surgically treated. Five (56%) were unplanned excisions. All these patients were reoperated on to attempt wide resection margins. In a patient, an infra-patellar amputation was performed. Another amputation was refused by another patient. Eight patients received adjuvant radiotherapy. Results: One patient died 8 years after amputation for a reason other than LMS. The patient who refused amputation has been alive, disease-free, for 28 months. The mean follow-up of surviving patients was 39 months (6–78 months). In these patients, there were no local recurrences or metastases. The mean functional outcome according to the MSTS score was 28.9 (range: 24–30). Conclusions: Unplanned excision of GSV-LMS can be prevented through clinical and imaging suspicion. Surgery and re-excision in case of inadequate previous margins and adjuvant radiotherapy lead to a good oncological and functional outcome.
24 June 2026 in Revista Española de Cirugía Ortopédica y Traumatología
Cancer negatively impacts the physical, psychological, social, and spiritual dimensions of individuals. In musculoskeletal sarcomas, medical care prioritizes somatic aspects. The primary objective was to assess the impact of a musculoskeletal sarcoma diagnosis on anxiety, depression, and health-related quality of life (HRQoL). Secondary objectives included analyzing the one-year evolution of these variables and the predominant coping profile. A prospective multicenter study with a concurrent control group (116 cases with musculoskeletal sarcomas and 67 controls with benign tumors) was conducted. The HADS and GAD-7 scales were administered to assess depression and anxiety, the QLQ-C30 to evaluate HRQoL, and the CERQ to assess coping strategies, with reassessment in the cases group one year after diagnosis. Outcomes were compared between groups, along with their evolution and the influence of epidemiological, demographic, sociolabor, oncological, functional (MSTS), and health-related variables. At diagnosis, cases showed higher prevalence of anxiety (64.7% vs. 40.3%; p=0.005) and poorer HRQoL (62.1±21.0 vs. 69.4±22.8; p=0.019) than controls, with no differences in depression. Anxiety and depression were associated with tumor stage (p=0.01), increasing in advanced stages. In the cases group, anxiety significantly decreased after one year (β=-1.51; 95% CI: -2.38 to -0.63; p=0.001). Oncological and functional outcomes were negatively associated with emotional evolution and QoL. An adaptive coping style predominated in 71% of patients. Most patients with musculoskeletal sarcomas develop adaptive coping styles. However, emotional disturbances and their association with oncological and functional outcomes justify comprehensive interventions that include psychological care.